Prevention & care
Pulmonary function tests: airflow, lung volumes, gas transfer and technical quality
On this page
Pulmonary function tests are breathing measurements. They examine how much air moves, how quickly it moves and, with additional methods, how gases transfer into blood. Spirometry is one member of this family, rather than a complete examination of every aspect of lung health.[1]
Common quantities on the report
| Test or quantity | What it examines | Interpretation boundary |
|---|---|---|
| FEV1 | Air forcibly exhaled during the first second | Read with the total forced exhalation and test quality[2] |
| FVC | Total air exhaled during the forced vital-capacity maneuver | Low FVC alone does not establish restriction[3] |
| Total lung capacity | Total air held after a full inspiration | This includes air that remains after breathing out[1] |
| DLCO | Carbon-monoxide transfer measured with a specified breathing procedure | Hemoglobin and other conditions affect the result[4] |
A forced breath measures a maneuver
Spirometry requires a full inhalation followed by a forceful exhalation into a mouthpiece. FEV1 and FVC are its main measured variables. These values come from the performed maneuver, not directly from an image of diseased tissue. Operator coaching, a good mouth seal and cooperation matter. The technical standard grades acceptability and repeatability, because a result cannot be interpreted confidently without knowing how the measurement was obtained.[2]
Air remaining in the lungs has its own measurement
Body plethysmography examines lung volume, including air remaining after as much air as possible has been exhaled. Leaving some air behind is normal. Some laboratories use other volume-measurement methods. Spirometry and lung-volume testing therefore should not be collapsed into one number. ATS explains that the selected tests depend on the question: some people need one or two methods, while others need a fuller set.[1]
Gas-transfer results depend on the measurement conditions
The DLCO standard describes carbon-monoxide uptake in the lungs using a single-breath method. The result is influenced by hemoglobin, lung volume, carbon monoxide already associated with hemoglobin, inspired oxygen, body position and exercise. This is why recording relevant conditions and applying the method’s interpretation rules matters. DLCO is not simply a direct percentage of oxygen in the blood, nor can an isolated value identify one unique lung disease.[4]
Opening the airways and provoking narrowing are different tests
Bronchodilator reversibility testing checks the airflow response to an airway-opening medicine. A bronchial challenge examines how readily the airways narrow when exposed to a controlled stimulus. These are different questions; a referral for one should not be read as an order for the other.[7]
Diagnostic sensitivity is the proportion of people with a condition who test positive. Diagnostic specificity is the proportion without that condition who test negative. The two measures use different groups of people.[10]
Direct challenges such as methacholine act on airway smooth muscle. Indirect challenges, including exercise or mannitol, trigger narrowing through other airway pathways. The 2017 European Respiratory Society (ERS) standard explains why their sensitivity and specificity differ. Results from these methods are not interchangeable.[8]
Tell the laboratory about a recent chest illness
Cambridge University Hospitals’ methacholine leaflet asks people with a recent chest infection or related antibiotic course to contact the department because testing may need rescheduling. The test involves repeated spirometry, monitored inhalations and medicine to reverse narrowing afterward. Report symptoms during testing; this describes a supervised clinical procedure, not a challenge to reproduce at home.[9]
Evidence & uncertainty
A physiological pattern is not a specific disease diagnosis. ERS/ATS interpretation guidance emphasizes clinical context, biological variation and measurement uncertainty. A value outside an expected range can guide investigation, but a threshold alone does not establish which condition caused the result.[3]
Selected-source overview · Independent review pendingPublished questions
Is spirometry a complete set of lung-function tests?
Selected-source overview · Independent review pending. Read the evidence context.
No. Lung volumes and gas-transfer studies answer additional questions. The clinician selects methods according to the suspected problem. A normal spirometry result cannot be expanded into a statement that every possible lung measurement is normal.[1]
Evidence behind this answer
- Pulmonary function tests
professional association explanation · Date not stated
Selected relevant original official educational passages inspected · Spirometry; diffusion; plethysmography; choosing methods
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does low FVC by itself prove restricted lungs?
Selected-source overview · Independent review pending. Read the evidence context.
No. ERS/ATS guidance uses total lung capacity to establish restriction and notes that a low FVC can need clarification. Interpret the combination of measurements and clinical context rather than attaching a disease label to one number.[3]
Evidence behind this answer
- ERS/ATS interpretive strategies for routine lung-function tests
technical or regulatory guidance · 2022
Original indexed technical-standard passages inspected; publisher full-text retrieval unavailable; no independent full-text appraisal · Physiological patterns, TLC confirmation, uncertainty and diagnostic boundary
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why are several forceful blows requested?
Selected-source overview · Independent review pending. Read the evidence context.
Repeatability gives information about whether the person reached their best volumes and how confidently the result can be interpreted. It is a quality check, rather than a series of independent disease tests. Coaching and technique are part of obtaining meaningful measurements.[2]
Evidence behind this answer
- Standardization of spirometry: 2019 update
technical or regulatory guidance · 2019
Original indexed technical-standard excerpts inspected; PMC open returned a browser challenge; no independent full-text appraisal · Primary variables; cooperation; acceptability; repeatability; cough
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can the blood’s hemoglobin level affect DLCO?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. Hemoglobin is among the conditions affecting measured carbon-monoxide transfer. The testing and interpretation procedures need to account for relevant information. DLCO should not be treated as a context-free measure of lung damage.[4]
Evidence behind this answer
- Single-breath carbon-monoxide uptake standards
technical or regulatory guidance · 2017
Original indexed abstract and official standard excerpts inspected; publisher full text unavailable and older ATS PDF link returned 404; no independent full-text appraisal · DLCO definition and conditions influencing transfer
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should inhalers always be stopped before PFTs?
Selected-source overview · Independent review pending. Read the evidence context.
No universal rule applies to every ordered examination. Follow the clinician’s specific instructions and never stop medicines solely on the basis of a general preparation list. The intended test condition determines what information is useful.[5]
Evidence behind this answer
- Lung function tests
agency condition or prevention explanation · Date not stated
Selected relevant original official educational passages inspected · Preparation, medicines and patient experience
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should symptom-free adults routinely be screened for COPD?
Selected-source overview · Independent review pending. Read the evidence context.
The USPSTF recommends against this screening. That recommendation has defined exceptions and does not apply to evaluation of respiratory symptoms. Screening policy and diagnostic testing of a clinical concern answer different questions.[6]
Evidence behind this answer
- COPD screening recommendation
clinical guideline · 2022
Selected relevant original official educational passages inspected · Asymptomatic scope, exceptions and diagnostic distinction
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is an airway challenge the same as testing an inhaler response?
Selected-source overview · Independent review pending. Read the evidence context.
No. One assesses response to a bronchodilator; the other examines sensitivity to a stimulus that can narrow the airways. Ask which procedure was ordered.[7]
Evidence behind this answer
- Lung function
Clinical service methods explanation · Date not stated
Original substantive service page read; method categories only. Undated page; copyright is not used as publication year. · Tests performed: bronchodilator reversibility versus pharmacological bronchial challenge
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can challenge-test results settle an asthma diagnosis on their own?
Selected-source overview · Independent review pending. Read the evidence context.
Not by themselves. A methacholine result changes the probability of current asthma; symptom timing, medication effects and test method matter. The clinician interprets it with the history.[8]
Evidence behind this answer
- ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests
Professional technical methods standard · 2017
Fresh full original publisher text retrieved using Firecrawl after native 403. Selected abstract, mechanisms, indications, safety/preparation and interpretation passages read. No dosing, withholding interval or personal test-selection protocol supplied. · Direct/indirect challenges; indications; interpretation; recent symptoms, medicines and test conditions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Repeated efforts provide information about confidence
The 2019 spirometry standard states that repeatability helps show whether the person achieved their best forced volumes. A cough in the first second can make FEV1 unusable. Quality grading distinguishes acceptable from merely usable measurements, and FEV1 and FVC are graded separately. An apparent change between visits should therefore be assessed alongside quality information rather than assuming that every numerical difference represents a biological decline or improvement.[2]
Obstruction and restriction are distinct patterns
ERS/ATS guidance distinguishes reduced airflow from reduced total lung capacity. A low FEV1-to-FVC ratio supports an obstructive pattern. Restriction is defined using low total lung capacity; reduced FVC can also occur in other circumstances. Lung-volume measurement may therefore be needed to clarify the pattern. These physiological classifications organize investigation and do not independently distinguish all diseases capable of producing them.[3]
Follow the actual laboratory instructions
The ordering clinician may give instructions about inhalers, meals, smoking or activity before testing. Do not withhold an inhaler merely because an internet preparation list mentions it. Ask whether the examination should assess the usual treated state or another specified condition. Report difficulty performing the maneuver and any symptoms that develop.[5]
Testing symptoms is different from screening everyone
The USPSTF recommends against COPD screening in adults who do not report respiratory symptoms. Its recommendation does not apply to investigating chronic cough, breathlessness, sputum or wheezing, or to specified very-high-risk populations. That distinction prevents a statement about low-value population screening from being mistaken for advice to avoid clinically indicated lung assessment. A test can have a useful diagnostic role without being useful as an indiscriminate wellness screen.[6]
A challenge result changes a probability
The ERS standard treats methacholine as a way to change the probability of current asthma. A negative result is often more useful for making asthma unlikely when symptoms are current or recent. A positive result alone does not settle the diagnosis. Recent illness, medicines and the performed method can affect interpretation.[8]
References
- Pulmonary function tests
Professional association explanation
American Thoracic Society · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Spirometry; diffusion; plethysmography; choosing methods - Standardization of spirometry: 2019 update
Technical or regulatory guidance
Graham and colleagues / ATS and ERS · Content/publication date: 2019
Accessed: 2026-10-13 UTC · Original indexed technical-standard excerpts inspected; PMC open returned a browser challenge; no independent full-text appraisal
Cited sections: Primary variables; cooperation; acceptability; repeatability; cough - ERS/ATS interpretive strategies for routine lung-function tests
Technical or regulatory guidance
Stanojevic and colleagues / ERS and ATS · Content/publication date: 2022
Accessed: 2026-10-13 UTC · Original indexed technical-standard passages inspected; publisher full-text retrieval unavailable; no independent full-text appraisal
Cited sections: Physiological patterns, TLC confirmation, uncertainty and diagnostic boundary - Single-breath carbon-monoxide uptake standards
Technical or regulatory guidance
Graham and colleagues / ERS and ATS · Content/publication date: 2017
Accessed: 2026-10-13 UTC · Original indexed abstract and official standard excerpts inspected; publisher full text unavailable and older ATS PDF link returned 404; no independent full-text appraisal
Cited sections: DLCO definition and conditions influencing transfer - Lung function tests
Agency condition or prevention explanation
NIH / National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Preparation, medicines and patient experience - COPD screening recommendation
Clinical guideline
USPSTF · Content/publication date: 2022
Accessed: 2026-10-13 UTC · Selected relevant original official educational passages inspected
Cited sections: Asymptomatic scope, exceptions and diagnostic distinction - Lung function
Clinical service methods explanation
Gloucestershire Hospitals NHS Foundation Trust · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Original substantive service page read; method categories only. Undated page; copyright is not used as publication year.
Cited sections: Tests performed: bronchodilator reversibility versus pharmacological bronchial challengeService categories, not an individual diagnostic pathway.
- ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests
Professional technical methods standard
Coates, Wanger, Cockcroft and colleagues; ERS task force · Content/publication date: 2017
Accessed: 2026-10-20 UTC · Fresh full original publisher text retrieved using Firecrawl after native 403. Selected abstract, mechanisms, indications, safety/preparation and interpretation passages read. No dosing, withholding interval or personal test-selection protocol supplied.
Cited sections: Direct/indirect challenges; indications; interpretation; recent symptoms, medicines and test conditionsDated technical framework; method and clinical context affect interpretation.
- Methacholine Challenge Test
Clinical service patient information
Cambridge University Hospitals NHS Foundation Trust · Content/publication date: 2025
Accessed: 2026-10-20 UTC · Original substantive clinical leaflet read, including procedure, illness/screening, risks and document details. Specific dose/breathing schedules, rare-event lists and drug-withholding instructions are not adopted.
Cited sections: Purpose; repeated measurements; recent chest infection/antibiotics; monitoring and results; approval 12 February 2025/version 3Local supervised testing; the actual department decides preparation and rescheduling.
- Diagnostic Sensitivity and Specificity: for Clinical Laboratory Testing
Official laboratory education
US Centers for Disease Control and Prevention, laboratory training · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Root read complete two-page original extracted text. Only first-page diagnostic definitions and denominators adopted; no assay ranking, retesting rule, predictive-value shortcut or personal diagnosis. Older cdc.gov labtraining URL returned 404 and was not used as current content.
Cited sections: Page 1: diagnostic sensitivity and specificity definitions and distinct denominatorsDiagnostic performance terms; these percentages are not a reader’s individual probability of disease.
Scope & review
- Population
- General readers learning about clinical testing and consumer test claims; no individualized diagnosis
- Exposure or intervention
- Pulmonary function tests
- Comparison
- Indication-specific alternatives; screening, diagnostic evaluation and monitoring distinguished
- Outcomes
- Meaning of measurements, appropriate indications, collection requirements and limits of inference
- Timeframe
- A specimen or examination at a stated time; trends and follow-up depend on clinical context
- Jurisdiction
- Selected US agency sources, dated professional guidance and original international research; jurisdiction and eligibility are source-specific
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added a selectively sourced diagnostic-test explanation; qualified independent review remains pending.
- 2026-10-20 UTC: Added supported foundational, practical and evidence explanations after full target-body and relevant adjacent-coverage checks. Original sections, questions and sources preserved as exact prefixes; qualified review pending.
What this article still leaves open
- How should the laboratory’s reference equations and quality grade affect interpretation near a threshold?
- Which additional tests best explain symptoms when routine measurements are inconclusive?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.